Many companies featured on Money advertise with us. Opinions are our own, but compensation and
in-depth research may determine where and how companies appear. Learn more about how we make money.

Published: Jul 28, 2021 6 min read

Money is not a client of any investment adviser featured on this page. The information provided on this page is for educational purposes only and is not intended as investment advice. Money does not offer advisory services.

A person who was busy shopping, and is now left standing holding all of their purchases.
Kiersten Essenpreis for Money

Companies that benefited from stay-at-home orders have seen huge gains since March of 2020. But as offices reopen and we head back out into the world, it’s time to figure out what to do with all those “pandemic stocks.”

In just one example, Zoom started off last year around $70 per share and now sits around $370. Vaccine producers also took off — Moderna was just $20 before the pandemic hit the U.S. and is now over $300.

Just because the pandemic cloud appears to slowly be lifting, you shouldn’t necessarily drop all the COVID-19 stocks. For one, the highly contagious Delta variant underscores the fact that the coronavirus hasn't gone away. And even when it eventually does, some of the changes the pandemic has wrought — or accelerated — might be here to stay.

“Make sure you have a portfolio that would benefit if trends have changed because of the pandemic,” says Sam Stovall, chief investment strategist at CFRA Research in New York City.